AMA
Sokolewicz E, Dzwilewski K, Omieczyńska N, Zawadzka M, Mazurkiewicz-Bełdzińska M. Drug resistant epilepsy as the consequence of inadequate control
of type 1 diabetes. Pediatric Endocrinology Diabetes and Metabolism. 2024;30(1):42-44. doi:10.5114/pedm.2024.137890.
APA
Sokolewicz, E., Dzwilewski, K., Omieczyńska, N., Zawadzka, M., & Mazurkiewicz-Bełdzińska, M. (2024). Drug resistant epilepsy as the consequence of inadequate control
of type 1 diabetes. Pediatric Endocrinology Diabetes and Metabolism, 30(1), 42-44. https://doi.org/10.5114/pedm.2024.137890
Chicago
Sokolewicz, Ewa M., Kamil Dzwilewski, Natalia Omieczyńska, Marta Zawadzka, and Maria Mazurkiewicz-Bełdzińska. 2024. "Drug resistant epilepsy as the consequence of inadequate control
of type 1 diabetes". Pediatric Endocrinology Diabetes and Metabolism 30 (1): 42-44. doi:10.5114/pedm.2024.137890.
Harvard
Sokolewicz, E., Dzwilewski, K., Omieczyńska, N., Zawadzka, M., and Mazurkiewicz-Bełdzińska, M. (2024). Drug resistant epilepsy as the consequence of inadequate control
of type 1 diabetes. Pediatric Endocrinology Diabetes and Metabolism, 30(1), pp.42-44. https://doi.org/10.5114/pedm.2024.137890
MLA
Sokolewicz, Ewa M. et al. "Drug resistant epilepsy as the consequence of inadequate control
of type 1 diabetes." Pediatric Endocrinology Diabetes and Metabolism, vol. 30, no. 1, 2024, pp. 42-44. doi:10.5114/pedm.2024.137890.
Vancouver
Sokolewicz E, Dzwilewski K, Omieczyńska N, Zawadzka M, Mazurkiewicz-Bełdzińska M. Drug resistant epilepsy as the consequence of inadequate control
of type 1 diabetes. Pediatric Endocrinology Diabetes and Metabolism. 2024;30(1):42-44. doi:10.5114/pedm.2024.137890.
